Atlas Trials

Efficacy and Safety in a Randomised Acute Pain Study of MR308 (Tramadol/Celecoxib).

Clinical trial NCT02982161 · COMPLETED

Trial details

NCT number
NCT02982161
Sponsor
Mundipharma Research GmbH & Co KG
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Pain
Start date
2016-12-28
Primary completion
2018-01-04
Enrollment
818

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.